Tdap Vaccination for Infant Caregivers
This study has been completed.
Sponsor:
Yale University
Collaborator:
Saint Raphael Healthcare System
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT01233401
First received: November 1, 2010
Last updated: July 26, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.
| Condition | Intervention |
|---|---|
|
Pertussis Vaccination |
Other: Survey |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Cross-Sectional |
| Official Title: | Tdap Vaccination for Infant Caregivers in the Pediatric Office |
Resource links provided by NLM:
Further study details as provided by Yale University:
Primary Outcome Measures:
- Maternal Tdap Vaccination Rate [ Time Frame: At 2 week well child visit ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Other Infant Caregiver Tdap Vaccination Rate [ Time Frame: At 2 week well child visit ] [ Designated as safety issue: No ]
| Enrollment: | 102 |
| Study Start Date: | June 2010 |
| Study Completion Date: | June 2011 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Mothers |
Other: Survey
Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.
|
|
Other Infant Caregivers
Includes fathers, grandparents, and other adults who are infant caregivers
|
Other: Survey
Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.
|
Eligibility| Ages Eligible for Study: | 18 Years to 64 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
18-64 year old men and women who are mothers or other infant caregivers of 2 week old infants
Criteria
Inclusion Criteria:
- 18-64 years old
- English or Spanish speaking
Exclusion Criteria:
- Do not speak English or Spanish
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01233401
Locations
| United States, Connecticut | |
| Hospital of St. Raphael | |
| New Haven, Connecticut, United States, 06511 | |
Sponsors and Collaborators
Yale University
Saint Raphael Healthcare System
Investigators
| Principal Investigator: | Deepa R Camenga, MD | Yale University |
| Principal Investigator: | Marjorie Rosenthal, MD MPH | Yale University |
More Information
No publications provided
| Responsible Party: | Deepa Camenga, MD, Yale University |
| ClinicalTrials.gov Identifier: | NCT01233401 History of Changes |
| Other Study ID Numbers: | 1005006837 |
| Study First Received: | November 1, 2010 |
| Last Updated: | July 26, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Yale University:
|
Pertussis, Vaccination, Adult |
Additional relevant MeSH terms:
|
Whooping Cough Bordetella Infections Gram-Negative Bacterial Infections Bacterial Infections |
Respiratory Tract Infections Infection Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 16, 2013